These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10568064)

  • 21. Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
    Rubio-Lotvin B; Gonzales-Ansorena R
    Acta Eur Fertil; 1978 Mar; 9(1):1-6. PubMed ID: 696184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of 1,668 cycles of triphasic oral contraception (Trigynon). Multicentric Belgian study].
    Gaspard U; Bouffioux R; Werbrouck-Navette J
    Rev Med Liege; 1982 Nov; 37(22):768-76. PubMed ID: 6818654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
    Bifano M; Sevinsky H; Hwang C; Kandoussi H; Jiang H; Grasela D; Bertz R
    Antivir Ther; 2014; 19(5):511-9. PubMed ID: 24343001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical study of transdermal contraceptive patch in Thai adolescence women.
    Piyasirisilp R; Taneepanichskul S
    J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris. A pilot study.
    Sator PG; Schmidt JB; Hönigsmann H
    Dermatology; 2003; 206(3):241-8. PubMed ID: 12673082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prediction of the effect of a triphasic contraceptive agent with norgestimate on acne].
    Cibula D; Paseka J; Unzeitig V; Horejsí J; Rotta L; Chroust K
    Ceska Gynekol; 2000 Mar; 65(2):79-82. PubMed ID: 10953475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with a low-dose contraceptive agent. European studies.
    Haspels AA
    J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
    Tantbirojn P; Taneepanichskul S
    Contraception; 2002 Dec; 66(6):401-5. PubMed ID: 12499031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
    Hampton RM; Fisher AC; Pagano S; LaGuardia KD
    Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A low-dose combination oral contraceptive. Experience with 1,700 women treated for 22,489 cycles.
    Woutersz TB
    J Reprod Med; 1981 Dec; 26(12):615-20. PubMed ID: 7033528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen.
    Brucker C; Hedon B; The HS; Höschen K; Binder N; Christoph A
    Contraception; 2010 Jun; 81(6):501-9. PubMed ID: 20472117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol.
    Lawson JS; Yuliano SE; Pasquale SA; Osterman JJ
    Am J Obstet Gynecol; 1979 Jun; 134(3):315-20. PubMed ID: 377968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of the secondary effects associated with taking a triphasic anti-ovulatory contraceptive].
    Vekemans M
    Rev Med Brux; 1984 Jan; 5(1):13-9. PubMed ID: 6701404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
    Shoupe D
    Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Side effects of oral contraceptives in the first treatment cycle].
    Feichtinger W; Babor P; Herczeg KM; Heyda M; Hoffmann R; Plöckinger B; Steinhauser B
    Wien Med Wochenschr; 1991; 141(18-19):412-5. PubMed ID: 1837965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick S; Kaye JA; Li L; Jick H
    Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.
    Kaunitz AM; Burkman RT; Fisher AC; LaGuardia KD
    Obstet Gynecol; 2009 Dec; 114(6):1205-1212. PubMed ID: 19935020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.